The present invention is directed to a microfluidic plasma extraction and metering thereof from whole blood.
Separation of plasma from whole blood is a key step within whole-blood testing for clinical diagnostics and biomedical research purposes. Blood sampling is conventionally done through venipuncture and collection of 5-10 ml whole blood in a tube. For analysis, plasma is usually the preferred substance and is obtained through centrifugation in the centralized laboratory prior to analysis. An alternative collection method to handling liquid samples in tubes, is to apply the blood on a paper material and allow the sample to dry in on the paper. In the laboratory, the dried blood can be re-dissolved and prepared for analysis through wet chemistry. This method is called Dried Blood Spot analysis (DBS) and when combined with a separation technology for retaining blood cells, one can also obtain Dried Plasma Spots (DPS). This methodology has gained popularity as it brings the advantage of no requirement for maintaining a cold chain during transportation to the lab. The simplicity of the storage format also opens up for capillary home sampling by finger prick.
Microfluidic systems and Lab-on-Chips are solutions for reducing time and cost of biochemical assays. Through miniaturization, the volumes to be analyzed are reduced which shortens reaction times and reduces the consumption of expensive reagents amongst other. Microfluidic technology have been applied for plasma extraction purposes. Separation of blood cells from plasma on the microscale can be achieved by either active (externally applied force such as electrical- or magnetic field) or passive (sedimentation, filtration or hydrodynamic effects induced by microfeatures. Further paper based, and centrifugal microfluidics also can be applied.
Many biochemical analyses require quantitation of analytes. To determine the precise concentration of an analyte in a sample, knowledge of the precise sample volume is required. On a microfluidic level, metering of liquids can again be achieved actively or passively. Examples of active means of dividing a volume of fluid into two or more volumes are by introducing components such as active valves that mechanically interfere with the liquid volume to split it up in units or passive valves in combination with pressurized air that can tear of parts of a liquid. In droplet microfluidics, shear forces that appears between two immiscible liquid phases (oil and water) in certain microfluidic geometries (T-junctions) are exploited for liquid compartmentalization. Passive metering has been less reported in the literature. WO2016/209147 demonstrates passive metering using two dissolvable membranes integrated in a microchannel. Further, US2015/0147777 A1 uses intersecting over spill channel structures containing absorbing materials for metering. WO2015/044454 discloses a microfluidic device for collecting and transporting biofluids, preferably whole blood that includes a metering channel for collecting of a metered sample. This device has a first region with a low flow resistance, comprising inlet features, and a second region comprising the metering channel with a high flow resistance, which is an arrangement that may cause problems related to obtain a stable performance adapted to different flows resulting from variations in blood characteristics.
It is desirable to enable completely autonomous systems for plasma sampling brings with advantage of minimal requirement of interaction from the user to run the process, thereby allowing a reduced training level of the user and reduced risk of errors during sampling. An autonomous system by passive means on a microfluidic level would further reduce the complexity and cost of the system, as no external driving forces requiring power sources etc. are required to run the microfluidic functions. To develop such a system would, however, involves the design challenge to comply with a tolerance to a wide range of whole blood characteristics in terms of varying hematocrit, lipid content and coagulation factors which vary largely between individuals, because these variances generate differences in flow characteristics in the system which would be easier to manipulate by allowing active flow manipulation. The present invention is directed to improvements that solves the mentioned problems, while resulting in a volume defined plasma sample.
It is an object of the invention to provide a microfluidic device transporting and metering a sample derived from whole blood with improvements in independency from variations in blood characteristics.
It is an object of the invention to provide a microfluidic device transporting and metering a sample derived from whole blood that is free from time dependent components and that is autonomous and self-supporting.
In one general aspect, the invention relates to a microfluidic device for transporting and sampling a defined volume of plasma, providing a fluid passageway from an inlet to an outlet. The device comprises a first region with the inlet, said first region having a first flow resistance and said first region being configured to receive and collect a whole blood sample and to separate plasma. The device further comprises a second region with the outlet, said second region having a second flow resistance and said second region is in fluid connection with the first region, and is configured to meter the separated plasma. The device further comprises a means for separating the first and the second region; and a capillary means in fluid communication with the outlet and configured to exert sufficiently strong capillary force to transport and absorb the metered plasma volume in the second region, while separating the plasma in the second region from the plasma in the first region. The second region is arranged with at least one air vent and the device according to this aspect admits an effective first flow resistance in the first region that is at least double the value of an effective second flow resistance in the second region, at any given time when transporting plasma.
In this aspect, the term “effective flow resistance” relates to the fact the flow resistance throughout the process of microfluidic transport through the device is dynamic and gradually changes as liquid is replaced by air in the fluid flow.
In this general aspect of the invention, the first region of the device can comprise a plasma extraction compartment comprising the inlet. The plasma extraction compartment is configured to receive and collect a whole blood sample and to separate plasma from the sample for further transport in the device. The second region comprises a metering channel in fluid connection with the outlet and the plasma extraction compartment by means of the fluid connector, preferably the metering channel has a volume of between 0.5 μl and 50 μl. More preferably, the volume of the metering channel is between 1-30 μl.
The defined volume of the metering channel generally determines the context of a microfluidic device and the term “microfluidic” according to the present invention.
In this general aspect of the invention, the plasma extraction compartment comprises at least one of a whole blood reservoir, a plasma separation membrane, and a plasma filtrate chamber for collecting and further transporting the separated plasma. Preferably, but not necessarily, the device is provided with each of a whole blood reservoir, a plasma separation membrane, and a plasma filtrate chamber for collecting and further transporting the separated plasma.
In one embodiment of the microfluidic device the means for separating the first and second region is a connecting channel between the plasma extraction chamber and the metering channel. In this embodiment the connecting channel preferably has a linear extension from the plasma extraction compartment, for example from a plasma filtration chamber to the metering channel. Preferably, the connecting channel and the metering channel have different dimensions. Such dimensions include, but are not limited to cross-sectional area and length, preferably, the connection channel has a lower cross-sectional area than the metering channel.
In one embodiment, the connecting channel is linked to the metering channel with an abrupt change in dimension.
In one embodiment, the connection channel meets the metering channel in a sharp corner so longitudinal symmetry axes of said connection and metering channels cross at an angle that is 90°, or less.
In one embodiment, the device comprises a metering channel with at least one branch with a dead end.
In one embodiment, the device has a connection channel that meets the metering channel so that it divides the metering channel in two asymmetric parts, a first part connected the outlet with longer filling time than a second part. Such a system may be configured as generally T-shaped.
In one embodiment of the device, a first part of the metering channel is a longer part (L1) connected to the outlet and a second part of the metering channel is a short part. (L2) connected to a dead end, for example, the relation of L1:L2 is 5:4 or 4:3, or from 5:4 to 4:3, or in another example, the longer part (L1) has at least the double length compared to the length of the shorter part (L2).
In another embodiment of the microfluidic device according to the invention, the means for separating the first and the second region is a fluid connector extending between an outlet orifice of the plasma extraction compartment and an inlet of the metering channel, the fluid connector is provided with an air vent (
In another embodiment of the microfluidic device according to the invention, the means for separating the first and the second region is an air vent located between the plasma filtrate chamber and the metering channel, thereby acting as an interface between the first and the second region of different flow resistance.
In one embodiment, the capillary means of the device is a porous matrix, such as paper, optionally covered by a dissolvable film, such as a film comprising PVA.
In one embodiment, the capillary means of the device is a capillary channel, such as a hydrophilic microfluidic channel being able to empty plasma from the metering channel.
In the device as defined in any earlier embodiment, the blood reservoir can be arranged to limit blood influx to the plasma separation membrane. The blood reservoir suitably is configured to be adapted to the volume of the metering channel and is configured so that the metering channel only can be filled once. Preferably, the volume of the blood reservoir is between 1-200 μl, more preferably 5-200 μl, and still more preferably 10-100 μl.
The device as defined in any earlier embodiment, may comprise a bridging element extending between the outlet and the capillary means. A bridging element serve as a means to support fluid communication between the outlet and the capillary means.
The device as defined in any earlier embodiment, may comprise one or several air vents arranged at suitable a position selected from at least one of: the whole blood reservoir, the metering channel, the outlet region. Preferably, a vent is arranged in the whole blood reservoir connected to the plasma separation membrane, a vent is arranged in a branch of the metering channel and a vent is arranged in connection with the outlet.
In another general aspect of the invention, it pertains to methods of obtaining a metered volume of plasma from a sample of whole blood with undefined volume. The method comprises the steps of: (a) receiving a whole blood sample at the inlet of a structure providing a plasma microfluidic passageway; (b) separating plasma from whole blood and transporting at a first flow resistance plasma from a plasma extraction chamber to a metering channel in said fluid passageway; (c) admitting the plasma to fill the metering channel at a second flow resistance, lower than the first flow resistance, and through an outlet establishing liquid contact with a capillary means; (d) emptying the metering channel by the capillary force of the capillary means, while shearing off plasma remaining in the fluid passageway; and (e) obtaining a plasma sample with a metered volume in the capillary means.
In the so described method or methods, it described how a microfluidic device with a microfluidic passageway is capable of partitioning or shearing off a metered volume plasma so a volume defined sample is provided in the capillary means and any remaining plasma is kept in the system, preferably, in the plasma extraction chamber and essentially in a region with higher flow resistance of the passageway.
In different embodiments of the method or methods it may comprise filling at least one short branch of the metering channel with a dead end and subsequently filling a longer branch of the metering channel with the outlet and thereby establish liquid contact with the capillary means.
The different methods as outlined here are suitably can be performed with any of the earlier embodied devices.
The follow detailed and exemplifying part describe particular embodiments of the invention that aim at be illustrative and should not be regarded as limiting for the scope of the invention as outlined in the claims.
The invention is now described, by way of example, with reference to the accompanying drawings, in which:
In another alternative embodiment to the device depicted in
The particular design of the systems solve several challenging issues in extraction and metering of plasma in microfluidic systems by passive means:
The partitioning of the metered plasma from surplus plasma is achieved by shearing off the liquid at the metering- and connecting channel intersection. The shearing off appears due to a number of coexisting factors. The higher flow resistance in the connecting channel (which appears through the resistance of the membrane in the plasma extraction compartment) than in the metering channel, enables that upon contact with the paper, fluid is pulled from point b towards a in the metering channel rather from pulling fluid from point c, the plasma extraction compartment. The sharp corners of the inlet into the metering channel and the angle V of 90° or less between the connecting channel and metering channel cuts the liquid surface when the meniscus passes it, disabling the cohesion between the plasma in metering and connecting channel.
The exemplified system is tolerant to a variation in filling times of the metering channel which could be caused by variations in blood characteristics between individuals such as for example hematocrit. This is because the system has no event time dependent components, e.g. dissolvable valves for pinch/shear off
The exemplified system is also tolerant to a variation in filling times of the metering channel which could be caused by mechanical variations and tolerances of the channels. This feature is achieved by the asymmetrical placement of the inlet from the connecting channel into the metering channel where L1>L2, so that there is a margin for the open channel path to complete filling first.
The exemplified placement of the intersection of the membrane extraction compartment and the metering channel towards the middle (but not at the middle) of the metering channel entails a stronger capillary force acting as capillary pump for the plasma extraction compartment rather than placing the plasma extraction compartment at the end of the metering channel (b). This is as two channels has stronger capillary force than one and promotes faster extraction rates.
After metering and absorption in the paper disc, the metering channel starts to re-fill. By limiting the input volume through a closed plasma extraction compartment, a second metering of surplus plasma is prevented. The closed plasma extraction compartment further prevents evaporation and contamination of the sample during the extraction process which can be as long as 30 min.
The invention is useful for example in biochemical analysis, therapeutic drug monitoring, screening of nutrients such as Vitamin D, Ferritin, and toxicological screening.
Number | Date | Country | Kind |
---|---|---|---|
1830253-9 | Sep 2018 | SE | national |
1950149-3 | Feb 2019 | SE | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/SE2019/050837 | 9/5/2019 | WO | 00 |